Attending the #AACR23 workshop on Clinical Trial Design and Challenges in Clinical Trial Enrollment (MW003)? Check out this Science in Society perspective in Blood Cancer Discovery on racial disparities in #myeloma trial participation— https://t.co/dq1ie3H
Congrats! Dr Anderson's impactful research in @BCD_AACR includes: https://t.co/w4ht6JIbJk https://t.co/v1UZXxRgDY
RT @_TanyaBondar_: I knew Tiffany Williams @MYELOMAHope as a contributor to practical recommendations on eliminating racial disparities in…
I knew Tiffany Williams @MYELOMAHope as a contributor to practical recommendations on eliminating racial disparities in myeloma therapies https://t.co/v1UZXxzFfo. What a great pleasure meeting her in person and learning about her inspiring journey. Thank
.@CraigEmmittCole discusses racial disparities in access to cutting-edge #myeloma therapies: https://t.co/eUtjvMYbLd https://t.co/pNMQ2rFS19
RT @BCD_AACR: @CraigEmmittCole talks on racial disparities in access to cutting-edge #myeloma therapies: https://t.co/KDznUXy03o @FDAOncolo…
RT @BCD_AACR: @CraigEmmittCole talks on racial disparities in access to cutting-edge #myeloma therapies: https://t.co/KDznUXy03o @FDAOncolo…
@CraigEmmittCole talks on racial disparities in access to cutting-edge #myeloma therapies: https://t.co/KDznUXy03o @FDAOncology @fredhutch @theNCI @EmoryMedicine @DanaFarberNews #IMS2022 https://t.co/UZSm4Jd3iP
RT @DaveGennert: Read recommendations published in @BCD_AACR from academic/industry/regulatory/patient stakeholders for steps to reduce dis…
Read recommendations published in @BCD_AACR from academic/industry/regulatory/patient stakeholders for steps to reduce disparities in #myeloma trial participation and outcome: https://t.co/VJPMoktmKV
Increasing clinical trial patient diveristy is crucial for achieving equitable health outcomes. Learn more at #AACR22 session ED011, and read principles to address racial disparities in #myeloma: https://t.co/Q8vxB4aXyM https://t.co/tk6te8Yxx0
Corroborated by @NCCN Policy Report (https://t.co/sjaRqvNOsn) which recommended "Future legislation @HHSGov regulatory initiatives should continue to encourage diverse population participation in trials & provide incentives to researchers to include u
For post-drug approval trials, that same FDA/AACR working group (https://t.co/MFvrPQjXej) recommended 1) Trial design should encompass disease subtypes and features most commonly seen in African Americans. ...
RT @NorthTxMSG: The FDA/AACR working group that I was a part of (https://t.co/MFvrPQjXej) recommended that preapproval trials 1) Set concr…
The FDA/AACR working group that I was a part of (https://t.co/MFvrPQjXej) recommended that preapproval trials 1) Set concrete targets for trial enrollment based on disease epidemiology 2) Prespecify analyses and endpoints to be assessed in racial subgroup
RT @AuclairDan: Finally on the 50th anniversary of the signing of the #NationalCancerAct : @AACR @FDAOncology Recommendations on Elimi…
RT @AuclairDan: Finally on the 50th anniversary of the signing of the #NationalCancerAct : @AACR @FDAOncology Recommendations on Elimi…
Finally on the 50th anniversary of the signing of the #NationalCancerAct : @AACR @FDAOncology Recommendations on Eliminating Racial Disparities in Multiple #Myeloma Therapies: A Step toward Achieving #Equity in Healthcare #mmsm https://t.co/9c5BK1NIO
@chadinabhan @ASH_hematology AACR in collaboration with FDA have developed similar recommendations towards equity in myeloma clinical trials: https://t.co/I7PD77mWQK The challenge is upon all of us to implement them in practice.
@TheyFearTheHare @ThisMorningCall @TywysogM @PoliticsForAlI @Telegraph https://t.co/pNC5bfM39d It's pretty clear to see why a diversity officer would improve patient health outcomes. By removing unconscious they can better ensure that they are hiring the
RT @mtmdphd: Recommendations on Eliminating Racial Disparities in Multiple Myeloma Therapies: A Step toward Achieving Equity in Healthcare…
RT @mtmdphd: Recommendations on Eliminating Racial Disparities in Multiple Myeloma Therapies: A Step toward Achieving Equity in Healthcare…
Recommendations on Eliminating Racial Disparities in Multiple Myeloma Therapies: A Step toward Achieving Equity in Healthcare [Feb 18, 2021] Nicole Gormley et al. @BCD_AACR https://t.co/e7KjlrKVwf #mmsm #cancerdisparities https://t.co/nuNO7DSWf4
RT @MalinHultcrantz: Important recommendations on ways to eliminate racial disparities in myeloma. Thank you Dr. Gormley et al @BCD_AACR #m…
RT @MalinHultcrantz: Important recommendations on ways to eliminate racial disparities in myeloma. Thank you Dr. Gormley et al @BCD_AACR #m…
RT @MalinHultcrantz: Important recommendations on ways to eliminate racial disparities in myeloma. Thank you Dr. Gormley et al @BCD_AACR #m…
RT @MalinHultcrantz: Important recommendations on ways to eliminate racial disparities in myeloma. Thank you Dr. Gormley et al @BCD_AACR #m…
Important recommendations on ways to eliminate racial disparities in myeloma. Thank you Dr. Gormley et al @BCD_AACR #mmsm #BHM https://t.co/Hr6sTcslDI
New article: Recommendations on Eliminating Racial Disparities in Multiple Myeloma Therapies: A Step toward Achieving Equity in Healthcare https://t.co/HH3n0q3xzg #MMSM #MultipleMyeloma #hematology https://t.co/mJuOTqQwwy
New article: Recommendations on eliminating racial disparities in multiple myeloma therapies: a step toward achieving equity in healthcare https://t.co/4L0VH62mPL #MMSM #MultipleMyeloma #hematology https://t.co/tXsMSwP5mR
Here are the recommendations towards achieving this goal, worked out by the panelists: https://t.co/GJL5exyVle
They spoke of changes in clinical trials urgently needed to make cancer care more equitable. Practical steps to accomplish it are delineated here: https://t.co/xVb0ScAyE6
RT @AuclairDan: Perfect time to recirculate as we start #NationalMinorityHealthMonth : Recommendations on Eliminating Racial Disparities in…
RT @AuclairDan: Perfect time to recirculate as we start #NationalMinorityHealthMonth : Recommendations on Eliminating Racial Disparities in…
RT @AuclairDan: Perfect time to recirculate as we start #NationalMinorityHealthMonth : Recommendations on Eliminating Racial Disparities in…
RT @BCD_AACR: Science in Society— @FDAOncology-@AACR Recommendations on Eliminating Racial Disparities in Multiple #Myeloma Therapies: A…
RT @BCD_AACR: Science in Society— @FDAOncology-@AACR Recommendations on Eliminating Racial Disparities in Multiple #Myeloma Therapies: A…
RT @BCD_AACR: Science in Society— @FDAOncology-@AACR Recommendations on Eliminating Racial Disparities in Multiple #Myeloma Therapies: A…
RT @AuclairDan: Perfect time to recirculate as we start #NationalMinorityHealthMonth : Recommendations on Eliminating Racial Disparities in…
RT @AuclairDan: Perfect time to recirculate as we start #NationalMinorityHealthMonth : Recommendations on Eliminating Racial Disparities in…
RT @AuclairDan: Perfect time to recirculate as we start #NationalMinorityHealthMonth : Recommendations on Eliminating Racial Disparities in…
RT @AuclairDan: And this one also #NationalMinorityHealthMonth #mmsm https://t.co/6UNFIkCbKX https://t.co/0O3ujov4vV
RT @AuclairDan: Perfect time to recirculate as we start #NationalMinorityHealthMonth : Recommendations on Eliminating Racial Disparities in…
And this one also #NationalMinorityHealthMonth #mmsm https://t.co/6UNFIkCbKX
RT @AuclairDan: Perfect time to recirculate as we start #NationalMinorityHealthMonth : Recommendations on Eliminating Racial Disparities in…
Perfect time to recirculate as we start #NationalMinorityHealthMonth : Recommendations on Eliminating Racial Disparities in Multiple Myeloma Therapies: A Step toward Achieving Equity in Healthcare #mmsm https://t.co/9c5BK25jGd
RT @BCD_AACR: Science in Society— @FDAOncology-@AACR Recommendations on Eliminating Racial Disparities in Multiple #Myeloma Therapies: A…
Science in Society— @FDAOncology-@AACR Recommendations on Eliminating Racial Disparities in Multiple #Myeloma Therapies: A Step toward Achieving Equity in Healthcare. @fredhutch @theNCI @EmoryMedicine @DanaFarberNews https://t.co/XP1p6fu8k9 https://t.
Interested in learning more about #DataDiversity? This paper from researchers at @US_FDA focuses on racial disparities in Multiple Myeloma therapy development and offers a roadmap to addressing disparities in clinical trials. #MindTheDataGap #healthcare h
RT @BCD_AACR: Science in Society— @FDAOncology-@AACR Recommendations on Eliminating Racial Disparities in Multiple #Myeloma Therapies: A…
RT @BCD_AACR: Science in Society— @FDAOncology-@AACR Recommendations on Eliminating Racial Disparities in Multiple #Myeloma Therapies: A…
RT @BCD_AACR: Science in Society— @FDAOncology-@AACR Recommendations on Eliminating Racial Disparities in Multiple #Myeloma Therapies: A…
Science in Society— @FDAOncology-@AACR Recommendations on Eliminating Racial Disparities in Multiple #Myeloma Therapies: A Step toward Achieving Equity in Healthcare. @fredhutch @theNCI @EmoryMedicine @DanaFarberNews https://t.co/GTUmvrtEvg https://t.
RT @IMFjimMYELOMA: Congratulations @NorthTxMSG and @MYELOMAhope for your meaningful article evaluating diversity in clinical trials, especi…
RT @IMFjimMYELOMA: Congratulations @NorthTxMSG and @MYELOMAhope for your meaningful article evaluating diversity in clinical trials, especi…
RT @IMFjimMYELOMA: Congratulations @NorthTxMSG and @MYELOMAhope for your meaningful article evaluating diversity in clinical trials, especi…
RT @IMFjimMYELOMA: Congratulations @NorthTxMSG and @MYELOMAhope for your meaningful article evaluating diversity in clinical trials, especi…
RT @IMFjimMYELOMA: Congratulations @NorthTxMSG and @MYELOMAhope for your meaningful article evaluating diversity in clinical trials, especi…
RT @IMFjimMYELOMA: Congratulations @NorthTxMSG and @MYELOMAhope for your meaningful article evaluating diversity in clinical trials, especi…
RT @IMFjimMYELOMA: Congratulations @NorthTxMSG and @MYELOMAhope for your meaningful article evaluating diversity in clinical trials, especi…
RT @BCD_AACR: Science in Society— @FDAOncology-@AACR Recommendations on Eliminating Racial Disparities in Multiple #Myeloma Therapies: A…
Congratulations @NorthTxMSG and @MYELOMAhope for your meaningful article evaluating diversity in clinical trials, especially outlining how to improve the current status.
RT @BCD_AACR: Science in Society— @FDAOncology-@AACR Recommendations on Eliminating Racial Disparities in Multiple #Myeloma Therapies: A…
Science in Society— @FDAOncology-@AACR Recommendations on Eliminating Racial Disparities in Multiple #Myeloma Therapies: A Step toward Achieving Equity in Healthcare. @fredhutch @theNCI @EmoryMedicine @DanaFarberNews https://t.co/ZQxbXOIk85 https://t.
Read AACR-FDA recommendations on eliminating racial disparities in multiple #myeloma therapies: https://t.co/QdtJGf4qpA
RT @flatironhealth: We can’t change the past, but we can and must rewrite history to include the missing chapters. Flatiron is proud to hav…
ICYMI: FDA-AACR Recommendations on Eliminating Racial Disparities in Multiple #Myeloma Therapies: A Step toward Achieving Equity in Healthcare. @FDAOncology @AACR @fredhutch @theNCI @EmoryMedicine @DanaFarberNews https://t.co/dfxf2pagkg https://t.co/cF0D0
RT @mtmdphd: Recommendations on Eliminating Racial Disparities in Multiple Myeloma Therapies: A Step toward Achieving Equity in Healthcare…
RT @mtmdphd: Recommendations on Eliminating Racial Disparities in Multiple Myeloma Therapies: A Step toward Achieving Equity in Healthcare…
RT @mtmdphd: Recommendations on Eliminating Racial Disparities in Multiple Myeloma Therapies: A Step toward Achieving Equity in Healthcare…
Recommendations on Eliminating Racial Disparities in Multiple Myeloma Therapies: A Step toward Achieving Equity in Healthcare [Feb 18, 2021] Nicole Gormley et al. @BCD_AACR https://t.co/e7KjlrKVwf #mmsm #cancerdisparities
RT @TMSchmidtMD: Such an important initiative! We must all strive for equity and inclusion in clinical trials and outcomes research. Recom…
RT @WinshipAtEmory: Winship hematologist @AjayNookaMD participated in a @FDAOncology and @AACR led workshop looking to eliminate racial bia…
RT @mtmdphd: Recommendations on Eliminating Racial Disparities in Multiple Myeloma Therapies: A Step toward Achieving Equity in Healthcare…
RT @mtmdphd: Recommendations on Eliminating Racial Disparities in Multiple Myeloma Therapies: A Step toward Achieving Equity in Healthcare…
Recommendations on Eliminating Racial Disparities in Multiple Myeloma Therapies: A Step toward Achieving Equity in Healthcare [Feb 18, 2021] Nicole Gormley et al. @BCD_AACR https://t.co/e7KjlrKVwf #mmsm #cancerdisparities https://t.co/G6bw5g3wNW
We can’t change the past, but we can and must rewrite history to include the missing chapters. Flatiron is proud to have contributed to this important work, eg via Kathleen Maignan’s participation in this 2020 FDA-AACR Workshop https://t.co/JWLa68iP0R
RT @rschilsky: Recommendations on Eliminating Racial Disparities in Multiple Myeloma Therapies: A Step toward Achieving Equity in Healthcar…
Recommendations on Eliminating Racial Disparities in Multiple Myeloma Therapies: A Step toward Achieving Equity in Healthcare https://t.co/QbASJDK8Pd
RT @TMSchmidtMD: Such an important initiative! We must all strive for equity and inclusion in clinical trials and outcomes research. Recom…
@NorthTxMSG @MYELOMAhope
Such an important initiative! We must all strive for equity and inclusion in clinical trials and outcomes research. Recommendations on Eliminating Racial Disparities in Multiple Myeloma Therapies: A Step toward Achieving Equity in Healthcare https://t.co/
RT @WinshipAtEmory: Winship hematologist @AjayNookaMD participated in a @FDAOncology and @AACR led workshop looking to eliminate racial bia…
RT @WinshipAtEmory: Winship hematologist @AjayNookaMD participated in a @FDAOncology and @AACR led workshop looking to eliminate racial bia…
Winship hematologist @AjayNookaMD participated in a @FDAOncology and @AACR led workshop looking to eliminate racial bias and improve representation of African Americans in #multiplemyeloma clinical trials. Recommendations published in @BCD_AACR. #mmsm
ICYMI: FDA-AACR Recommendations on Eliminating Racial Disparities in Multiple #Myeloma Therapies: A Step toward Achieving Equity in Healthcare. @FDAOncology @AACR @fredhutch@theNCI @EmoryMedicine @DanaFarberNews https://t.co/NFJqFdUZQf https://t.co/E9ZwrC
RT @AmgenOncology: Eliminating health disparities will take a team effort. @Amgen is proud to be part of these efforts, represented by our…
RT @AmgenOncology: Eliminating health disparities will take a team effort. @Amgen is proud to be part of these efforts, represented by our…
RT @AmgenOncology: Eliminating health disparities will take a team effort. @Amgen is proud to be part of these efforts, represented by our…
Eliminating health disparities will take a team effort. @Amgen is proud to be part of these efforts, represented by our executive medical director Khalid Mezzi, an author on this paper. #multiplemyeloma
RT @AACR: These recommendations were developed at an AACR-@FDAOncology Workshop to Examine Under-representation of African Americans in Mul…
RT @_TanyaBondar_: Science In Society: @US_FDA and @AACR propose steps to equity in clinical advances in myeloma https://t.co/L21d97sBKt #M…
RT @AACR: These recommendations were developed at an AACR-@FDAOncology Workshop to Examine Under-representation of African Americans in Mul…
These recommendations were developed at an AACR-@FDAOncology Workshop to Examine Under-representation of African Americans in Multiple Myeloma Clinical Trials, co-chaired by @BCD_AACR Editor-in-Chief and #AACRFellows Kenneth Anderson. Watch the workshop: h
RT @AuclairDan: The last meeting many of us attended in person since Covid hit @CraigEmmittCole @myelomaMD @IreneGhobrial @NorthTxMSG @agar…
RT @FDAOncology: FDAOncology's @pkluetz @LolaFashoyinAje and Dr. Nicole Gormley participated in the Feb 2020 FDA-@AACR workshop to develop…
RT @FDAOncology: FDAOncology's @pkluetz @LolaFashoyinAje and Dr. Nicole Gormley participated in the Feb 2020 FDA-@AACR workshop to develop…